![Decorative image.](/media/h5ndirk5/1792x900-riad-m-large-banner.png?width=1792&height=900&v=133525683404270000&format=webp)
Results materials
2023 financial highlights
Newsroom
All news stories Latest news
Featured
Hikma delivers strong 2023 performance and a positive outlook for 2024
Press Release, Financial Results 22 February 2024
- Hikma acquires Xellia’s differentiated portfolio and enhances Injectables pipeline, manufacturing capabilities and R&D Press Release, Corporate 17 June 2024 Hikma acquires Xellia’s differentiated portfolio and enhances Injectables pipeline, manufacturing capabilities and R&D
- Hikma Pharmaceuticals reaffirms commitment to expanding access to overdose-reversal medicine naloxone at White House meeting Press Release, Corporate 06 June 2024 Hikma Pharmaceuticals reaffirms commitment to expanding access to overdose-reversal medicine naloxone at White House meeting
- Hikma opens new UK office to support NHS supply, strengthening European presence Press Release, Corporate 03 June 2024 Hikma opens new UK office to support NHS supply, strengthening European presence
- Hikma enters the Spanish generic injectables market, strengthening its European presence Press Release, Corporate 20 May 2024 Hikma enters the Spanish generic injectables market, strengthening its European presence
Related content